Advanced Biomed ADVB Cash Flow Statement (2023-2026)

NASDAQ ADVB
$3.80 -0.36 (-8.65%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Advanced Biomed Quarterly Cash Flow Statement

Periods 10 quarters
Latest Mar 2026

Advanced Biomed reported cash from operations of -$0.24M and free cash flow of -$0.24M for the quarter ended Mar 2026, up 95.2% year over year. This cash flow statement covers 10 quarters of results from Dec 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income -0.15M-1.06M-0.81M-0.27M-0.91M-1.38M-0.70M-0.39M6.86M-0.49M
Depreciation and DepletionDep. & Depletion 0.06M0.05M0.12M0.07M0.02M0.02M0.16M0.05M0.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.06M0.08M0.15M0.10M-0.06M0.02M0.28M0.05M-0.01M0.01M
Cash from Discontinued OperationsCash from Discont. Ops 2.03M
Gains from Sales and DivestituresGains Divest 7.35M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp. -0.08M0.18M0.17M-0.13M-2.21M2.06M-0.23M-0.10M0.04M
Change in Other Operating AssetsOther Assets Change 0.01M0.00M0.04M-0.04M2.05M0.72M0.05M-0.70M-0.20M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M-312.00-246.00-0.03M0.01M
Other Working Capital ChangesOther WC Changes -0.01M0.00M-0.04M0.04M-2.05M-0.75M-0.04M0.70M0.20M
Cash from OperationsCash from Ops. -1.07M-0.48M-0.03M-0.84M-5.04M0.09M-0.61M-0.51M-0.24M
Investing Activities
Capital ExpendituresCapex -0.03M0.05M0.02M-0.01M0.00M0.02M0.00M0.01M0.00M
Change in Property, Plant and EquipmentChange in PP&E 0.03M-0.05M-0.02M0.01M0.00M-0.02M0.00M-0.01M0.00M
Cash from Investing ActivitiesCash from Investing 0.03M-0.05M-0.02M0.01M0.00M-0.02M0.00M-0.01M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.53M0.41M0.41M0.10M0.26M0.51M0.46M-0.32M0.00M
Long-Term Debt RepaymentsLT Debt Repayment 0.00M0.84M0.01M0.01M
Non-Current Debt 0.53M0.41M0.41M0.10M0.26M-0.32M0.45M-0.33M0.00M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.53M0.41M0.41M0.10M0.26M-0.32M0.45M-0.33M0.00M
Change in Capital Stock
Common Stock IssuedStock Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Net Shares Issued and RepurchasedNet Shares Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Net Equity Issued and RepurchasedNet Equity Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Other financing activitiesOther financing 0.00M
Cash from Financing ActivitiesCash from Financing 0.56M0.32M0.39M0.41M5.90M-0.77M0.45M0.32M0.27M
Additional items
Exchange Rate EffectFX Effect 0.36M0.15M-0.30M0.37M0.07M0.08M-0.08M0.29M
Change in Cash -0.11M-0.06M0.04M0.01M2.53M-2.28M-0.25M-0.05M0.00M
Ending Cash Balance 2.78M2.66M2.61M2.65M2.66M5.18M2.90M2.66M2.61M2.61M
Free Cash FlowFCF -1.04M-0.53M-0.05M-0.83M-5.04M0.07M-0.61M-0.53M-0.24M
Net Cash FlowNCF -0.48M-0.21M0.34M-0.42M0.86M-0.70M-0.16M-0.21M0.03M
Interest Paid -90.00-112.00

Advanced Biomed Cash Flow Statement API

Pull Advanced Biomed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADVB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY